BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ling J, Chan BC, Tsang MS, Gao X, Leung PC, Lam CW, Hu J, Wong CK. Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine. Front Med 2022;8:815075. [DOI: 10.3389/fmed.2021.815075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Scarpellini C, Ramos Llorca A, Lanthier C, Klejborowska G, Augustyns K. The Potential Role of Regulated Cell Death in Dry Eye Diseases and Ocular Surface Dysfunction. Int J Mol Sci 2023;24. [PMID: 36614174 DOI: 10.3390/ijms24010731] [Reference Citation Analysis]
2 Zhao X, Yu Z, Li D, Duan J. Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Qiju Dihuang Pill against Dry Eye Disease. Comput Math Methods Med 2022;2022:7316794. [PMID: 36590763 DOI: 10.1155/2022/7316794] [Reference Citation Analysis]
3 Zhang G, Fu W, Xu J, Hu P, Zhang Y, Sang Z, Wu W, Zheng K, Wu L, Liu Z. Moxibustion with Walnut Shell Spectacles Could Improve the Objective Symptoms and Tear Film Stability of Patients with Dry Eye Disease: A Randomized Controlled Trial. Evid Based Complement Alternat Med 2022;2022:1773444. [PMID: 36506807 DOI: 10.1155/2022/1773444] [Reference Citation Analysis]
4 Yang M, Wang Y. Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases. J Ophthalmol 2022;2022:8071406. [PMID: 35646393 DOI: 10.1155/2022/8071406] [Reference Citation Analysis]